Showing 7801-7810 of 8648 results for "".
- Can You Get COVID-19 Through Your Eyes? Possibly.https://modernod.com/news/can-you-get-covid-19-through-your-eyes-possibly/2478112/We know that the coronavirus can enter the body through the nose and mouth — hence the constant recommendations from doctors to wear face coverings and practice social distancing. But what abou
- Sanofi, GSK Gain $2.1 Billion From US Government for Development, Supply of COVID-19 Vaccinehttps://modernod.com/news/sanofi-gsk-gain-2-1-billion-from-us-government-for-development-supply-of-covid-19-vaccine/2478107/Sanofi and GlaxoSmithKline announced that the US government will provide more than $2.1 billion to support further development, manufacturing and delivery of initial doses of the companies’ adjuvanted vaccine against COVID-19. The vaccine candidate is based on Sanofi’s recombinant pro
- The Vision Council Releases 2019 Vision Watch Cataract Reporthttps://modernod.com/news/the-vision-council-releases-2019-vision-watch-cataract-report/2478110/The Vision Council recently released the results of the 2019 VisionWatch Cataract Report. Conducted in December 2019, the study measures changes in consumer behavior related to vision and vision correction after undergoing cataract surgery. The intent of the study was to explore how cataract surg
- Which HCPs Are Most Likely to Get COVID Vaccine?https://modernod.com/news/which-hcps-are-most-likely-to-get-covid-vaccine/2478106/Physicians are the most likely group of healthcare professionals to get a COVID-19 vaccine when one is available, according to a new Medscape poll. More than 7,000 healthcare professionals, including clinicians, medical students, an
- iOR Partners Welcomes Tom Frinzi to their Boardhttps://modernod.com/news/ior-partners-welcomes-tom-frinzi-to-their-board/2478104/iOR Partners, a provider of office-based surgery in ophthalmology, announced that industry veteran Tom Frinzi has joined their Board of Directors. “We are thrilled that Tom Frinzi is joining our Board. He bring
- New Topline Tepezza Data Underscore its Efficacy in Potential for Retreatment in People Living with Thyroid Eye Disease (TED)https://modernod.com/news/new-topline-tepezza-data-underscore-its-efficacy-in-potential-for-retreatment-in-people-living-with-thyroid-eye-disease-ted/2478101/Horizon Therapeutics announced positive topline data from two clinical trials that add to the growing body of evidence supporting the efficacy and safety of Tepezza (teprotumumab-trbw) for the treatment of Thyroid Eye Disease (TED). Tepezza is the first and only medicine approved by the FDA for t
- How COVID-19 Causes Smell Losshttps://modernod.com/news/how-covid-19-causes-smell-loss/2478103/Temporary loss of smell, or anosmia, is the main neurological symptom and one of the earliest and most commonly reported indicators of COVID-19. Studies suggest it better predicts the disease than other well-known symptoms such as fever and cough, but the underlying mechan
- Vitamin B3 Shows Promise for Glaucoma Patients in Clinical Trialhttps://modernod.com/news/vitamin-b3-shows-promise-for-glaucoma-patients-in-clinical-trial/2478100/A clinical trial led by the Center for Eye Research Australia has shown that vitamin B3 (nicotinamide) could play an important role in protecting against nerve cell damage that leads to blindness in glaucoma, according to a
- J&J Vaccine Protects Monkeys From Covid With Single Shothttps://modernod.com/news/jj-vaccine-protects-monkeys-from-covid-with-single-shot/2478099/Johnson & Johnson’s experimental coronavirus vaccine protected a group of macaques with a single shot in an early study, prompting the U.S. drugmaker to start trials in humans this month, according to a Bloomberg
- Methotrexate Treat-and-Extend Tested for Vitreoretinopathyhttps://modernod.com/news/methotrexate-treat-and-extend-tested-for-vitreoretinopathy/2478096/A treat-and-extend regimen of methotrexate can be used to successfully treat proliferative vitreoretinopathy, according to a series of 50 eyes in which 96% of retinas were successfully reattached, Medscape reported. “I’